Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

Cerebral small vessel disease (SVD) is a major contributor to stroke, cognitive impairment and dementia with limited therapeutic interventions. There is a critical need to provide mechanistic insight and improve translation between pre-clinical research and the clinic. A 2-day workshop was held which brought together experts from several disciplines in cerebrovascular disease, dementia and cardiovascular biology, to highlight current advances in these fields, explore synergies and scope for development. These proceedings provide a summary of key talks at the workshop with a particular focus on animal models of cerebral vascular disease and dementia, mechanisms and approaches to improve translation. The outcomes of discussion groups on related themes to identify the gaps in knowledge and requirements to advance knowledge are summarized.

Seth Love | Jason Berwick | Jozien Goense | Tao Wang | Maiken Nedergaard | Hugh S Markus | Joanna M Wardlaw | Adam Harvey | Lisa M Saksida | M. Z. Cader | Anne Joutel | Rikesh M. Rajani | Philip M Bath | Patrick G Kehoe | L. Saksida | Steven C. R. Williams | J. Goense | J. Berwick | S. Love | P. Kehoe | R. Carare | M. Nedergaard | M. Macleod | B. McColl | J. Wardlaw | Colin Smith | R. Touyz | H. Markus | R. Kalaria | Kenneth J. Smith | T. Quinn | A. Hainsworth | A. Harvey | S. Allan | P. Bath | J. Duncombe | L. Work | A. Joutel | T. Farr | J. Fowler | Catherine Hall | K. Horsburgh | C. Lawrence | R. Trueman | C. McCabe | Anna C. Williams | Rosalind Brown | I. Macrae | Malcolm R Macleod | John B Davis | Rhian M Touyz | Cheryl A Hawkes | Malcolm R Macleod | Steven C R Williams | Anna Williams | C. Hawkes | P. Meakin | Barry W McColl | Kenneth J Smith | Stuart M Allan | Colin Smith | M Zameel Cader | Terry J Quinn | Paul J Meakin | Roxana O Carare | Rajesh N Kalaria | I Mhairi Macrae | Alessandra Granata | Lorraine M Work | Catherine B Lawrence | Karen Horsburgh | Atticus H Hainsworth | Tom van Agtmael | Mike L J Ashford | Rosalind Brown | Jessica Duncombe | Tracy D Farr | Jill H Fowler | Catherine N Hall | Andy Lockhart | Chris McCabe | Alyson Miller | Michael O'Sullivan | Rikesh Rajani | Rebecca C Trueman | M. Ashford | T. Van Agtmael | John B. Davis | A. Granata | Tao Wang | Tao Wang | Alyson A Miller | H. Markus | Michael J. O’Sullivan | S. Williams | Andy Lockhart | Jill H. Fowler | Tom Van Agtmael | Joanna M. Wardlaw | Jill H. Fowler | Karen Horsburgh | Tracy D. Farr | Patrick G. Kehoe | Malcolm R Macleod | I. Macrae | Steven C.R. Williams | M. Cader | Joanna M. Wardlaw | Stuart M. Allan | Mike L.J. Ashford | P. M. Bath | John B. Davis | Catherine N. Hall | Cheryl Hawkes | Rajesh N. Kalaria | Catherine B. Lawrence | Andy Lockhart | Seth Love | Malcolm R. Macleod | Hugh S. Markus | Christopher Mccabe | Michael O'Sullivan | Terry J Quinn | Colin Smith | Kenneth J. Smith | Anna Williams | Cheryl A Hawkes | R. Kalaria | Steven C.R. Williams | Adam P. Harvey

[1]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[2]  H. Markus,et al.  Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Ian Marshall,et al.  Cerebral blood flow in small vessel disease: A systematic review and meta-analysis , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[5]  K. Fujihara,et al.  Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination , 2010, Acta Neuropathologica.

[6]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[7]  N. Plesnila,et al.  Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , 2015, Annals of neurology.

[8]  A M Owen,et al.  Computerized assessment in neuropsychiatry using CANTAB: discussion paper. , 1992, Journal of the Royal Society of Medicine.

[9]  C. Sobey,et al.  Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation , 2014, Journal of hypertension.

[10]  D. Borchelt,et al.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.

[11]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[12]  B. Zlokovic The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[13]  G. Biessels Diagnosis and treatment of vascular damage in dementia. , 2016, Biochimica et biophysica acta.

[14]  C. Sudlow,et al.  Etiology of Stroke and Choice of Models , 2012, International journal of stroke : official journal of the International Stroke Society.

[15]  D. Werring,et al.  Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling , 2014, Proceedings of the National Academy of Sciences.

[16]  R. Kalaria,et al.  Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. , 2017, Clinical science.

[17]  Jan Warnking,et al.  Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI , 2011, NeuroImage.

[18]  M. Dichgans,et al.  Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. , 2015, Brain : a journal of neurology.

[19]  M. Fujishima,et al.  Vascular changes underlying cerebral lesions in stroke-prone spontaneously hypertensive rats , 2004, Acta Neuropathologica.

[20]  L. Wilkins Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL) , 2017, Neurology.

[21]  C. Labelle-Dumais,et al.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets , 2012, Human molecular genetics.

[22]  M. Bastin,et al.  Hypertension Fails to Disrupt White Matter Integrity in Young Or Aged Fisher (F44) Cyp1a1Ren2 Transgenic Rats , 2015, Journal of Cerebral Blood Flow and Metabolism.

[23]  M. Ihara,et al.  White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion , 2004, Stroke.

[24]  Reinhold Schmidt,et al.  Consensus statement for diagnosis of subcortical small vessel disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  M. Moss,et al.  Translational models for vascular cognitive impairment: a review including larger species , 2017, BMC Medicine.

[26]  Arvind Caprihan,et al.  Long-Term Blood–Brain Barrier Permeability Changes in Binswanger Disease , 2015, Stroke.

[27]  S. Dohgu,et al.  Tumor necrosis factor-α-stimulated brain pericytes possess a unique cytokine and chemokine release profile and enhance microglial activation , 2014, Neuroscience Letters.

[28]  Malcolm Macleod,et al.  How can we improve the pre-clinical development of drugs for stroke? , 2007, Trends in Neurosciences.

[29]  M. Esiri,et al.  Neuropathological assessment of the lesions of significance in vascular dementia , 1997, Journal of neurology, neurosurgery, and psychiatry.

[30]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[31]  P. Sandercock,et al.  Does Early Reperfusion of a Cerebral Infarct Influence Cerebral Infarct Swelling in the Acute Stage or the Final Clinical Outcome , 1993 .

[32]  Stroke Therapy Academic Industry Roundtable Recommendations for standards regarding preclinical neuroprotective and restorative drug development. , 1999, Stroke.

[33]  Daniel J. R. Christensen,et al.  Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.

[34]  W. Mcdonald,et al.  Central remyelination restores secure conduction , 1979, Nature.

[35]  K Broich,et al.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. , 2014, The journal of prevention of Alzheimer's disease.

[36]  C. Maxwell,et al.  Antihypertensive agents and prevention of dementia , 2010, BMJ : British Medical Journal.

[37]  V. Hachinski Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.

[38]  H. Lassmann,et al.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.

[39]  Joanna M. Wardlaw,et al.  Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial , 2015, The Lancet Neurology.

[40]  Lisa M Saksida,et al.  The touchscreen operant platform for testing working memory and pattern separation in rats and mice , 2013, Nature Protocols.

[41]  C. Dufouil,et al.  Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.

[42]  R O Weller,et al.  Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.

[43]  Junyang Jung,et al.  Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair , 2017, BioMed research international.

[44]  Thorbjørn S. Engedal,et al.  Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[46]  B. Zlokovic,et al.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.

[47]  A. Akhmedov,et al.  Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. , 2017, American journal of physiology. Heart and circulatory physiology.

[48]  A. Dominiczak,et al.  An MRI-Histological Study of White Matter in Stroke-Free SHRSP , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  M. Macleod,et al.  Emulating Multicentre Clinical Stroke Trials: A New Paradigm for Studying Novel Interventions in Experimental Models of Stroke , 2009, International journal of stroke : official journal of the International Stroke Society.

[50]  Jeffrey L Saver,et al.  The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.

[51]  C. Sudlow,et al.  Potential Animal Models of Lacunar Stroke: A Systematic Review , 2009, Stroke.

[52]  J. Hendrikse,et al.  Longitudinal Relationship Between Cerebral Small-Vessel Disease and Cerebral Blood Flow: The Second Manifestations of Arterial Disease-Magnetic Resonance Study , 2015, Stroke.

[53]  L. Kuller,et al.  Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults , 2013, Neurology.

[54]  Sean P. Palecek,et al.  Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.

[55]  A. W. Chung,et al.  Structural network efficiency is associated with cognitive impairment in small-vessel disease , 2014, Neurology.

[56]  A. Planas,et al.  Structural and functional brain alterations in a murine model of Angiotensin II‐induced hypertension , 2017, Journal of neurochemistry.

[57]  Lisa J. Martin,et al.  Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease , 2015, Neurology.

[58]  Stephanie Schäfer,et al.  What's Wrong With My Mouse?, J.N. Crawley. John Wiley and Sons Inc. (2000), Price: €92.00, ISBN: 0-471-31639-3 , 2007 .

[59]  Mark Woodward,et al.  Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke , 2016, Stroke.

[60]  J. Searcy,et al.  Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice. , 2017, Clinical science.

[61]  P. Rothwell,et al.  Carotid Artery Imaging for Secondary Stroke Prevention: Both Imaging Modality and Rapid Access to Imaging Are Important , 2009, Stroke.

[62]  Sean P. Palecek,et al.  An isogenic blood–brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells , 2017, Journal of neurochemistry.

[63]  G. E. Vates,et al.  A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.

[64]  V. Feigin,et al.  Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.

[65]  C. Sudlow,et al.  Pathology of Lacunar Ischemic Stroke in Humans—A Systematic Review , 2012, Brain pathology.

[66]  Jian-Mei Li,et al.  Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2 , 2014, British journal of clinical pharmacology.

[67]  Nancy Argüelles,et al.  Author ' s , 2008 .

[68]  Shinya Yamanaka,et al.  Induced pluripotent stem cell technology: a decade of progress , 2016, Nature Reviews Drug Discovery.

[69]  C. Iadecola,et al.  The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. , 2011, American journal of physiology. Heart and circulatory physiology.

[70]  V. Hachinski,et al.  Declining Incidence of Stroke and Dementia: Coincidence or Prevention Opportunity? , 2015, JAMA neurology.

[71]  V. Gudnason,et al.  Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study. , 2011, Brain : a journal of neurology.

[72]  T. Kitazono,et al.  Nox4 Is a Major Source of Superoxide Production in Human Brain Pericytes , 2014, Journal of Vascular Research.

[73]  U. Dirnagl,et al.  Neuroimaging Biomarkers Predict Brain Structural Connectivity Change in a Mouse Model of Vascular Cognitive Impairment , 2017, Stroke.

[74]  G. Marchal,et al.  PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.

[75]  N. Plesnila,et al.  Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia , 2015, Science Translational Medicine.

[76]  S. Pacini,et al.  Commentary: Structural and functional features of central nervous system lymphatic vessels , 2015, Front. Neurosci..

[77]  K. Fassbender,et al.  Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. , 2014, Current Alzheimer research.

[78]  D. Sosnowska,et al.  Cardiovascular and Cerebrovascular Aging–New Mechanisms and Insights: Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase , 2014 .

[79]  G. Mead,et al.  Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia , 2013, Alzheimer's & Dementia.

[80]  Joanna M. Wardlaw,et al.  Genes From a Translational Analysis Support a Multifactorial Nature of White Matter Hyperintensities , 2015, Stroke.

[81]  C. Ritchie,et al.  CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2017, The Cochrane database of systematic reviews.

[82]  T. Robbins,et al.  Assessing cognitive function in clinical trials of schizophrenia , 2010, Neuroscience & Biobehavioral Reviews.

[83]  E. Wood,et al.  Gliovascular Disruption and Cognitive Deficits in a Mouse Model with Features of Small Vessel Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[84]  P. Katakam,et al.  Role of Mitochondria in Cerebral Vascular Function: Energy Production, Cellular Protection, and Regulation of Vascular Tone. , 2016, Comprehensive Physiology.

[85]  I. Deary,et al.  Selective white matter pathology induces a specific impairment in spatial working memory , 2011, Neurobiology of Aging.

[86]  David A. Bennett,et al.  Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study , 2016, The Lancet Neurology.

[87]  N. Plesnila,et al.  Pericytes are involved in the pathogenesis of CADASIL , 2015 .

[88]  Jürgen Hennig,et al.  Ultra-fast magnetic resonance encephalography of physiological brain activity – Glymphatic pulsation mechanisms? , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[89]  L. Saksida,et al.  Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept) , 2011, The Journal of Neuroscience.

[90]  M. Chopp,et al.  White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies , 2017, Neurobiology of Aging.

[91]  Xavier Golay,et al.  Cause and prevention of demyelination in a model multiple sclerosis lesion , 2016, Annals of neurology.

[92]  M. Nedergaard,et al.  Garbage Truck of the Brain , 2013, Science.

[93]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[94]  C. Sudlow,et al.  Is the Spontaneously Hypertensive Stroke Prone Rat a Pertinent Model of Sub Cortical Ischemic Stroke? A Systematic Review , 2011, International journal of stroke : official journal of the International Stroke Society.

[95]  D. Norris,et al.  Nonlinear temporal dynamics of cerebral small vessel disease , 2017, Neurology.

[96]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[97]  A. Joutel,et al.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.

[98]  M. Nelson,et al.  Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain? , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[99]  Michael Chopp,et al.  Impairment of the glymphatic system after diabetes , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[101]  Martin Dichgans,et al.  Genetic factors in cerebral small vessel disease and their impact on stroke and dementia , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[102]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[103]  I. McKeith,et al.  Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study , 2009, PLoS medicine.

[104]  E. Rostrup,et al.  Quantitative and qualitative MRI evaluation of cerebral small vessel disease in an elderly population: a longitudinal study , 2018, Acta radiologica.

[105]  Michael Detmar,et al.  A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules , 2015 .

[106]  Maiken Nedergaard,et al.  Impairment of paravascular clearance pathways in the aging brain , 2014, Annals of neurology.

[107]  C. Leffler,et al.  Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF‐alpha in cerebral vascular endothelial cells. , 2009, American journal of physiology. Cell physiology.

[108]  Norbert Schuff,et al.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.

[109]  J. Wardlaw,et al.  Thrombectomy for Acute Ischemic Stroke. , 2015, JAMA.

[110]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[111]  S. Ananiadou,et al.  Risk of bias reporting in the recent animal focal cerebral ischaemia literature , 2017, Clinical science.

[112]  Z. Katušić,et al.  Endothelial nitric oxide: protector of a healthy mind. , 2014, European heart journal.

[113]  M. Mesulam,et al.  The Special Topics Section of Alzheimer's & Dementia , 2015, Alzheimer's & Dementia.

[114]  Joanna M. Wardlaw,et al.  Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability , 2016, NeuroImage.

[115]  R. Carare,et al.  The structure of the perivascular compartment in the old canine brain: a case study. , 2017, Clinical science.

[116]  G. Wang,et al.  Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations , 2015, Cellular and Molecular Neurobiology.

[117]  A. Tricco,et al.  Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[118]  E. Stip,et al.  Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB , 2007, European Psychiatry.

[119]  C. Sudlow,et al.  Differential gene expression in multiple neurological, inflammatory and connective tissue pathways in a spontaneous model of human small vessel stroke , 2014, Neuropathology and applied neurobiology.

[120]  S. Mandal,et al.  Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease , 2011, Free radical research.

[121]  D. Clair,et al.  Bridging the translational divide: identical cognitive touchscreen testing in mice and humans carrying mutations in a disease-relevant homologous gene , 2015, Scientific Reports.

[122]  Reinhard Schliebs,et al.  Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy , 2011, Acta Neuropathologica.

[123]  I. Cuthill,et al.  Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research † , 2012, Osteoarthritis and Cartilage.

[124]  B. Bell,et al.  CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. , 1985, Journal of neurosurgery.

[125]  R. Carare,et al.  Vascular basement membranes as pathways for the passage of fluid into and out of the brain Journal Item , 2018 .

[126]  K. Smith,et al.  Central demyelination induced in vivo by the calcium ionophore ionomycin. , 1994, Brain : a journal of neurology.

[127]  I. Deary,et al.  Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities , 2014, Neurology.

[128]  P. Heutink,et al.  Mutations in Col4a1 Cause Perinatal Cerebral Hemorrhage and Porencephaly , 2005, Science.

[129]  J. Crabbe,et al.  Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.

[130]  Kenneth J. Smith,et al.  Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide , 2005, Brain : a journal of neurology.

[131]  W. Markesbery,et al.  Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants , 2002, Annals of the New York Academy of Sciences.

[132]  S. Pendlebury,et al.  Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.

[133]  J. O'Brien,et al.  Imaging of neuroinflammation in dementia: a review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[134]  J. Wardlaw,et al.  Early life risk factors for cerebrovascular disease , 2017, Neurology.

[135]  A. Chalaris,et al.  Mechanistic insights into a TIMP3-sensitive pathway constitutively engaged in the regulation of cerebral hemodynamics , 2016, eLife.

[136]  T. Quinn,et al.  Diagnosis in vascular dementia, applying 'Cochrane diagnosis rules' to 'dementia diagnostic tools'. , 2017, Clinical science.

[137]  I. Deary,et al.  Carotid disease at age 73 and cognitive change from age 70 to 76 years: A longitudinal cohort study , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[138]  E. Hamel,et al.  Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease , 2013, British journal of pharmacology.

[139]  C. Lyketsos,et al.  Treatment for mild cognitive impairment: systematic review , 2013, British Journal of Psychiatry.

[140]  Maiken Nedergaard,et al.  Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury , 2014, The Journal of Neuroscience.

[141]  L. Wilkins Gradual Carotid Artery Stenosis in Mice Closely Replicates Hypoperfusive Vascular Dementia in Humans , 2016, Journal of the American Heart Association.

[142]  Per Kristian Eide,et al.  MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain , 2015, Acta radiologica open.

[143]  Thomas Steckler,et al.  Touching on translation , 2013, Cell and Tissue Research.

[144]  Jess Nithianantharajah,et al.  Cognitive components in mice and humans: Combining genetics and touchscreens for medical translation , 2013, Neurobiology of Learning and Memory.

[145]  Joanna M. Wardlaw,et al.  White matter hyperintensity reduction and outcomes after minor stroke , 2017, Neurology.

[146]  C. Sobey,et al.  Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. , 2012, Journal of applied physiology.

[147]  P. Passmore,et al.  Statins for the prevention of dementia. , 2016, The Cochrane database of systematic reviews.

[148]  P. Scheltens,et al.  Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment. , 2016, Stroke.

[149]  Marc Fisher,et al.  Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.

[150]  C. Iadecola,et al.  Dangerous Leaks: Blood-Brain Barrier Woes in the Aging Hippocampus , 2015, Neuron.

[151]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[152]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[153]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[154]  P. Flecknell,et al.  The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments) , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[155]  Geoffrey A. Donnan,et al.  Stroke Thrombolysis: Save a Minute, Save a Day , 2014, Stroke.

[156]  Klaus P. Ebmeier,et al.  METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research , 2016, Alzheimer's & Dementia.

[157]  N. Rothwell,et al.  A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[158]  H. Chabriat,et al.  Disruption of a miR‐29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathy , 2016, Annals of neurology.

[159]  F. Faraci Protecting against vascular disease in brain. , 2011, American journal of physiology. Heart and circulatory physiology.

[160]  Maiken Nedergaard,et al.  The Glymphatic System: A Beginner’s Guide , 2015, Neurochemical Research.

[161]  Timothy J Bussey,et al.  The touchscreen operant platform for testing learning and memory in rats and mice , 2013, Nature Protocols.

[162]  A. Dominiczak,et al.  Cerebral small vessel endothelial structural changes predate hypertension in stroke‐prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5‐ to 21‐week‐old rats , 2011, Neuropathology and applied neurobiology.

[163]  Andrew E Moran,et al.  Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet. Global health.

[164]  Peter Garrard,et al.  Experimental models of vascular dementia and vascular cognitive impairment: a systematic review , 2010, Journal of neurochemistry.

[165]  C. Iadecola,et al.  The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction , 2014, Nature Communications.

[166]  A. van den Berg,et al.  Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. , 2013, Lab on a chip.

[167]  M. Macleod,et al.  From a mouse: systematic analysis reveals limitations of experiments testing interventions in Alzheimer's disease mouse models , 2016, Evidence-based preclinical medicine.

[168]  J. Bond,et al.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.

[169]  Alan J. Thomas,et al.  Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia , 2015, Brain : a journal of neurology.

[170]  Jeffrey F. Thompson,et al.  Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[171]  Alexandra Naba,et al.  Overview of the matrisome--an inventory of extracellular matrix constituents and functions. , 2012, Cold Spring Harbor perspectives in biology.

[172]  A. D. de Craen,et al.  High Blood Pressure, Physical and Cognitive Function, and Risk of Stroke in the Oldest Old: The Leiden 85-Plus Study , 2013, Stroke.

[173]  Liping Liu,et al.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. , 2013, The New England journal of medicine.

[174]  H. Stöhr,et al.  Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice , 2016, Annals of neurology.

[175]  M. Macleod,et al.  Systematic Review and Meta-Analysis of Interventions Tested in Animal Models of Lacunar Stroke , 2014, Stroke.

[176]  S. Tsuji,et al.  Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. , 2009, The New England journal of medicine.

[177]  C. Iadecola,et al.  Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1 , 2017, Proceedings of the National Academy of Sciences.

[178]  J. C. de la Torre Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[179]  M. Murphy,et al.  Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. , 2016, Biochimica et biophysica acta.

[180]  B. Zlokovic,et al.  Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[181]  M. Trotter,et al.  Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility , 2012, Nature Biotechnology.

[182]  Masafumi Ihara,et al.  Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease , 2016 .

[183]  D. Wilcock,et al.  Vascular Contributions to Cognitive Impairment and Dementia: Topical Review of Animal Models. , 2016, Stroke.

[184]  J. Cooke,et al.  Overexpression of Dimethylarginine Dimethylaminohydrolase Protects Against Cerebral Vascular Effects of Hyperhomocysteinemia , 2010, Circulation research.

[185]  Brianne A. Kent,et al.  The touchscreen operant platform for assessing executive function in rats and mice , 2013, Nature Protocols.

[186]  M. Prunotto,et al.  Opportunities and challenges in phenotypic drug discovery: an industry perspective , 2017, Nature Reviews Drug Discovery.

[187]  P. Sandercock,et al.  Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.

[188]  R. Kalaria Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease , 2016, Acta Neuropathologica.

[189]  Dementia prevention: call to action , 2015, The Lancet.

[190]  J. Wardlaw,et al.  Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study , 2017, Trials.

[191]  Francesca M Chappell,et al.  Counting Cavitating Lacunes Underestimates the Burden of Lacunar Infarction , 2010, Stroke.

[192]  C. Lourenço,et al.  Neurovascular‐neuroenergetic coupling axis in the brain: master regulation by nitric oxide and consequences in aging and neurodegeneration , 2017, Free radical biology & medicine.

[193]  Tian Feng,et al.  The Effect of Body Posture on Brain Glymphatic Transport , 2015, The Journal of Neuroscience.